Baupost Group - Q4 2013 holdings

$3.53 Billion is the total value of Baupost Group's 19 reported holdings in Q4 2013. The portfolio turnover from Q3 2013 to Q4 2013 was 35.0% .

 Value Shares↓ Weighting
MU SellMICRON TECHNOLOGY INC$1,123,506,000
+0.5%
51,655,434
-19.3%
31.83%
-0.4%
THRX BuyTHERAVANCE INC$718,144,000
-5.1%
20,144,301
+8.8%
20.35%
-5.9%
VSAT BuyVIASAT INC$697,244,000
-0.4%
11,129,200
+1.2%
19.76%
-1.3%
BP BuyBP PLCsponsored adr$275,444,000
+17.1%
5,666,413
+1.2%
7.80%
+16.1%
IDIX BuyIDENIX PHARMACEUTICALS INC$220,727,000
+43.4%
36,910,868
+24.4%
6.25%
+42.1%
CWSA BuyCITIGROUP INC*w exp 01/04/201$67,760,000
-3.9%
104,246,007
+10.6%
1.92%
-4.7%
FNF NewFIDELITY NATIONAL FINANCIALcl a$64,069,0001,974,400
+100.0%
1.82%
R114PS  CHIPMOS TECH BERMUDA LTD$63,169,000
+7.0%
3,283,2350.0%1.79%
+6.1%
PBF BuyPBF ENERGY INCcl a$62,184,000
+190.0%
1,976,606
+106.9%
1.76%
+187.4%
NG  NOVAGOLD RES INC$55,088,000
+9.5%
21,688,3000.0%1.56%
+8.6%
ELOS  SYNERON MEDICAL LTD$49,200,000
+42.7%
4,000,0000.0%1.39%
+41.5%
ROVI SellROVI CORP$42,530,000
-64.0%
2,160,000
-64.9%
1.20%
-64.3%
KIN NewKINDRED BIOSCIENCES INC$32,393,0002,900,000
+100.0%
0.92%
AOI  ALLIANCE ONE INTL INC$19,470,000
+4.8%
6,383,6410.0%0.55%
+4.0%
AIGWS  AMERICAN INTL GROUP INC*w exp 01/19/202$13,293,000
+6.9%
656,4430.0%0.38%
+5.9%
NCQ  NOVACOPPER INC$7,608,000
-19.6%
5,005,2980.0%0.22%
-20.0%
AVEO  AVEO PHARMACEUTICALS INC$7,008,000
-11.2%
3,829,3500.0%0.20%
-11.6%
ALDW NewALON USA PARTNERS LPut ltdpart int$5,484,000329,188
+100.0%
0.16%
ENZN SellENZON PHARMACEUTICALS INC$5,032,000
-61.1%
4,337,858
-43.6%
0.14%
-61.2%
ITRN ExitITURAN LOCATION AND CONTROL$0-476,341
-100.0%
-0.25%
CPF ExitCENTRAL PAC FINL CORP$0-779,715
-100.0%
-0.39%
ExitMICRON TECHNOLOGY INCdebt 1.875% 6/0$0-11,367,000
-100.0%
-0.52%
ORCL ExitORACLE CORP$0-2,386,890
-100.0%
-2.26%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2014-02-13
Signatures

The EDGAR filing(s) were signed by:

About Baupost Group

Baupost Group is a Boston-based hedge fund founded by Seth Klarman in 1982. Klarman is a well-known value investor and author of the book "Margin of Safety". The firm has a reputation for being one of the most successful and secretive hedge funds in the world, with a focus on distressed debt, value investing, and event-driven strategies.

Baupost Group has a team of experienced investment professionals, including CEO and President James Mooney, COO Michael Apfel, and Chief Investment Officer Seth Klarman. The firm manages over $30 billion in assets and has a long-term investment horizon, often holding positions for several years.

The firm's investment philosophy is centered around the concept of margin of safety, which involves buying assets at a significant discount to their intrinsic value to minimize downside risk. Baupost Group is known for its disciplined approach to investing, conducting extensive research and analysis before making any investment decisions.

Baupost Group has a history of successful investments, including distressed debt investments in companies such as Enron and WorldCom. The firm also made a significant profit from its investment in the distressed debt of Lehman Brothers following the financial crisis.

Overall, Baupost Group is a highly respected hedge fund with a strong track record of successful investments. However, as with any investment, it is important for investors to conduct their own research and due diligence before making any investment decisions.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VIASAT INC42Q3 202320.0%
THERAVANCE BIOPHARMA INC38Q3 20234.2%
VERITIV CORP37Q3 202310.8%
ATARA BIOTHERAPEUTICS INC36Q3 20234.2%
TRILOGY METALS INC NEW29Q3 20230.4%
QORVO INC27Q3 20239.7%
CHENIERE ENERGY INC25Q1 202019.1%
THERAVANCE BIOPHARMA INC23Q2 20220.5%
NOVAGOLD RES INC22Q3 20181.9%
LIBERTY GLOBAL PLC21Q3 202316.6%

View Baupost Group's complete holdings history.

Latest significant ownerships (13-D/G)
Baupost Group Q4 2013 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Garrett Motion Inc.August 10, 20235,987,2892.3%
Theravance Biopharma, Inc.July 10, 20237,419,22612.8%
Outbrain Inc.May 09, 20234,720,0008.4%
Archaea Energy Inc.Sold outFebruary 14, 202300.0%
Liberty Media CorpFebruary 14, 20237,677,6567.8%
Altimeter Growth Corp. 2Sold outFebruary 13, 202300.0%
Avanti Acquisition Corp.Sold outFebruary 13, 202300.0%
Liberty Media Acquisition CorpSold outFebruary 13, 202300.0%
Liberty Media CorpFebruary 13, 202313,651,0486.2%
VERINT SYSTEMS INCSold outFebruary 13, 202300.0%

View Baupost Group's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G2024-02-13
SC 13G2024-02-13
SC 13G/A2024-01-09
42023-12-06
SC 13D/A2023-12-04
13F-HR2023-11-13

View Baupost Group's complete filings history.

Compare quarters

Export Baupost Group's holdings